To test our hypothesis that increased G9a/GLP methylation would enhance GC-induced apoptosis of B-ALL cells, we employed inhibitors that target each KDM family to find one that increased methylation levels of G9a. Here, EHMT2 is linked to acute lymphoblastic leukemia.